Investing.com -- Arcus Biosciences, Inc. (NYSE:RCUS) stock fell 8.75% on Friday after the company announced the pricing of a $250 million public offering of common stock.
Key Insights Notion VTec Berhad's estimated fair value is RM0.58 based on 2 Stage Free Cash Flow to Equity With ...
Broadcom posts strong growth, but valuation concerns and industry risks suggest caution. Click here to read my earnings ...
AbbVie Inc. is reiterated as a Strong Buy ahead of Q3 earnings, with revenue growth expected to outpace the sector median.
Pfizer's recent issues include poor financial results, looming patent cliffs, and the potential impact of tariffs. The company is addressing these issues by developing new medicines and negotiating ...
A JavaScript library to calculate bond prices, accrued interest, and yield-to-maturity (YTM) for Government and Corporate bonds, supporting multiple coupon frequencies and day-count conventions.
Hosted on MSN
How to work out if an investment trust at a discount is really a bargain: THE INVESTING ANALYST
Many investment trusts trade a discount. This means that canny investors can buy into ... Investment trusts are what is known as closed-ended funds, listed on the stock market with a limited number of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback